Researchers are studying whether these widely used weight-loss drugs may also be future treatments for alcohol abuse.

Treatment with incretin-based weight-loss medications, like GLP-1 receptor agonists, after bariatric surgery was associated with significantly lower risks of alcohol use disorder (AUD) and initiation ...

In a large U.S. retrospective cohort study published in JAMA Network Open, investigators report that glucagon-like peptide-1 ...

Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...

The FDA has approved Wegovy (semaglutide) tablets, the first oral GLP-1 receptor agonist for the treatment of obesity.

The FDA has approved the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for weight loss and to reduce the risk ...

A new study by Scripps Research reveals that alcohol dependence disrupts two signaling pathways in a stress-related part of ...

A new study by Scripps Research reveals that alcohol dependence disrupts two signaling pathways in a stress-related part of ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The FDA approved the first oral GLP-1 for lowering body weight according to a press release from Novo Nordisk. Oral ...

Intense pain during a bowel movement sent our son to the ER. He got diagnosed with a blood clot in a hemorrhoid and needed surgery to fix it.

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.